GPR15 and neoplasm: Similar to mice, the frequency of GPR15+ Tregs, but not that of GPR15+ Teffs, in the tumor sites of patients with CRC was significantly higher than that in non-tumor sites, suggesting a distinct role for GPR15 in Treg delivery to CRC sites in humans (10).